Douglas Ingram

Sarepta Therapeutics

President and Chief Executive Officer

Annual data

2017

In 2017, Douglas Ingram earned a total compensation of $56.9M as President and Chief Executive Officer at Sarepta Therapeutics.

Ranking20 out of 13,165
Percentile99.8%

Douglas Ingram's 2017 compensation ranked 20th out of 13,165 executive pay records tracked by us this year.

Douglas Ingram earned more than 99.8% of all executives tracked by us in 2018.

IndustryPharmaceutical preparations
Ranking1 out of 1,094
Percentile99.9%

In the industry of pharmaceutical preparations, Douglas Ingram's 2017 pay ranked 1st out of 1,094 executive pay records tracked by us.

Douglas Ingram earned more than 99.9% of executives in this industry.

Non-Equity Incentive Plan$420,875
Option Awards$44,484,000
Salary$337,500
Stock Awards$11,607,750
Other$16,116
Total$56,866,241

Ingram received $44.5M in option awards, which accounts for 78.23% of total compensation.

Ingram also received $420.9K in non-equity incentive plan, $337.5K in salary, $11.6M in stock awards and $16.1K in other compensation.